Centessa Pharmaceuticals Plc (CNTA)
26.96
+0.44
(+1.66%)
USD |
NASDAQ |
Feb 25, 16:00
26.90
-0.06
(-0.22%)
After-Hours: 20:00
Centessa Pharmaceuticals Shareholders Equity (Quarterly) : 301.57M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Silence Therapeutics Plc | 74.06M |
| Adaptimmune Therapeutics Plc | -70.96M |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | 34.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 448.30M |
| Total Liabilities (Quarterly) | 146.73M |
| Debt to Equity Ratio | 0.3921 |
| Current Ratio | 10.56 |
| Net Debt Paydown Yield | -0.20% |